-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Editor's note: clinical investigation
Feng Wang
Editor Note: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
Giving research participants their voice: assessing comprehension in the informed consent process
Judith Lowenburg Forman, Sandra Knowlton-Soho
Editorial: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
The presumption of benefit in clinical research with children and adolescents
Janet L Brody
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Evolving trial design in secondary progressive multiple sclerosis
Jeremy Chataway ,Susan Todd
Editorial: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
Combination therapy for COPD: emerging evidence from recent clinical trials
Matthew C Miles, James F Donohue, Jill A Ohar
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation